248 related articles for article (PubMed ID: 31250131)
1. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Ibuki M; Hasegawa K; Ishibuchi K; Tamaru H; Yasuda S; Ishii R; Nakabayashi S; Kusumoto H; Higashino Y
Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131
[TBL] [Abstract][Full Text] [Related]
2. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
[TBL] [Abstract][Full Text] [Related]
3. Effect of neointimal tissue morphology on vascular response to balloon angioplasty in lesions with in-stent restenosis after drug-eluting stent deployment: an optical coherence tomography analysis.
Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Shimatani Y; Hasegawa K; Ishibuchi K; Tamaru H; Ishii R; Yasuda S; Taniguchi Y; Nakabayashi S; Kusumoto H; Higashino Y
Heart Vessels; 2020 Sep; 35(9):1193-1200. PubMed ID: 32253529
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
[TBL] [Abstract][Full Text] [Related]
6. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
[TBL] [Abstract][Full Text] [Related]
7. The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation.
Isodono K; Fujii K; Fujimoto T; Kasahara T; Ariyoshi M; Irie D; Tsubakimoto Y; Sakatani T; Matsuo A; Inoue K; Fujita H
Int J Cardiovasc Imaging; 2021 Jan; 37(1):15-23. PubMed ID: 32734495
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
[No Abstract] [Full Text] [Related]
9. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
[TBL] [Abstract][Full Text] [Related]
10. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
[TBL] [Abstract][Full Text] [Related]
11. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
[TBL] [Abstract][Full Text] [Related]
14. Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
Rheude TA; Xhepa E; Byrne RA
Catheter Cardiovasc Interv; 2017 May; 89(6):E181-E184. PubMed ID: 27527355
[TBL] [Abstract][Full Text] [Related]
15. Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.
Hou J; Jia H; Liu H; Han Z; Yang S; Xu C; Schmitt J; Zhang S; Yu B; Jang IK
Int J Cardiovasc Imaging; 2012 Dec; 28(8):1879-86. PubMed ID: 22422037
[TBL] [Abstract][Full Text] [Related]
16. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
[TBL] [Abstract][Full Text] [Related]
17. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
18. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209
[TBL] [Abstract][Full Text] [Related]
19. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
[TBL] [Abstract][Full Text] [Related]
20. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells.
Nicol P; Hoppman P; Euller K; Xhepa E; Lenz T; Rai H; Jinnouchi H; Bulin A; Castellanos MI; Lahmann AL; Koppara T; Kastrati A; Joner M
Int J Cardiovasc Imaging; 2021 Jan; 37(1):25-35. PubMed ID: 32761285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]